Jan van Heek, a former Genzyme executive, has joined the supervisory board of the Dutch drug delivery company To-BBB Technologies BV. Mr van Heek is currently a partner at the consulting organization BioPoint Group. Previously he was a member of the senior management team at Genzyme (now Sanofi SA) and headed that company’s global therapeutics division. Prior to that he was a manager at Baxter Healthcare Corporation in Europe and the US.
To-BBB announced the appointment on 13 January 2014.
Copyright 2014 Evernow Publishing Ltd.